Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0257 Transporter Info | ||||
Gene Name | SLC2A2 | ||||
Transporter Name | Glucose transporter type 2, liver | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class 1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 5 TF(s) Regulating This DT |
|||||
CEBPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A2 gene in hepatoblastoma condition | [1] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein alpha | Transcription Factor Info | ||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
CCAAT/enhancer-binding protein alpha (CEBPA) has been reported to activate the transcription of SLC2A2 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Glucose transporter type 2. | |||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A2 gene in hepatoblastoma condition | [1] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) has been reported to activate the transcription of SLC2A2 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Glucose transporter type 2. | |||||
FOSL2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A2 gene | [2] | ||||
TF Protein Name |
Fos-related antigen 2 | Transcription Factor Info | ||||
Tissue |
Brain; Breast; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Fos-related antigen 2 (FOSL2) can directly bind to the SLC2A2 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 2. | |||||
JUND |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A2 gene | [3] | ||||
TF Protein Name |
Transcription factor JunD | Transcription Factor Info | ||||
Tissue |
Bone marrow; Brain; Colon; Coronary artery; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor JunD (JUND) can directly bind to the SLC2A2 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 2. | |||||
MAFB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A2 gene in diabetes mellitus condition | [4] | ||||
TF Protein Name |
Transcription factor MafB | Transcription Factor Info | ||||
Affected Drug/Substrate |
Insulin | |||||
Studied Phenotype |
Diabetes mellitus [ICD11: 5A10-5A14] | |||||
Tissue |
Pancreas | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6J mice | |||||
Detailed Description |
Transcription factor MafB (MAFB) has been reported to activate the transcription of SLC2A2 gene in diabetes mellitus condition, which leads to an increased expression of the drug transporter Glucose transporter type 2. | |||||
Class 1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SREBF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of GLUT2 gene in insulinoma condition | [5] | ||||
TF Protein Name |
Sterol regulatory element-binding protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
Insulinoma [ICD11: 2C10.1] | |||||
Tissue |
Pancreas | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/129OlaHsd mice | |||||
Detailed Description |
Sterol regulatory element-binding protein 1 (SREBF1) has been reported to activate the transcription of GLUT2 gene in insulinoma condition, which leads to an increased expression of the drug transporter Glucose transporter type 2. | |||||
Class 2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
NR1H2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of GLUT2 gene in insulinoma condition | [5] | ||||
TF Protein Name |
Oxysterols receptor LXR-beta | Transcription Factor Info | ||||
Studied Phenotype |
Insulinoma [ICD11: 2C10.1] | |||||
Tissue |
Pancreas | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/129OlaHsd mice | |||||
Detailed Description |
Oxysterols receptor LXR-beta (NR1H2) has been reported to activate the transcription of GLUT2 gene in insulinoma condition, which leads to an increased expression of the drug transporter Glucose transporter type 2. | |||||
PPARA |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A2 gene in hepatoblastoma condition | [6] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor alpha | Transcription Factor Info | ||||
Affected Drug/Substrate |
Insulin | |||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Peroxisome proliferator-activated receptor alpha (PPARA), influenced by the exogenous oleic Acid, has been reported to activate the transcription of SLC2A2 gene in hepatoblastoma condition , which leads to an increased expression of the drug transporter Glucose transporter type 2. | |||||
Transcriptional Phenomenon 2 |
Activation of SLC2A2 gene in type 2 diabetes condition | [7] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor alpha | Transcription Factor Info | ||||
Studied Phenotype |
Type 2 diabetes [ICD11: 5A11] | |||||
Tissue |
Pancreas | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Zucker diabetic fatty rat | |||||
Detailed Description |
Peroxisome proliferator-activated receptor alpha (PPARA) has been reported to activate the transcription of SLC2A2 gene in type 2 diabetes condition, which leads to an increased expression of the drug transporter Glucose transporter type 2. | |||||
Class 2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A2 gene | [8] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC2A2 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 2. | |||||
GATA3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A2 gene | [9] | ||||
TF Protein Name |
Trans-acting T-cell-specific transcription factor GATA-3 | Transcription Factor Info | ||||
Tissue |
Blood; Brain; Breast; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) can directly bind to the SLC2A2 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 2. | |||||
Class 2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A2 gene | [2] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC2A2 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 2. | |||||
Class 3.1: Homeo domain factors |
Click to Show/Hide the Full List of 7 TF(s) Regulating This DT |
|||||
CDX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A2 gene in health condition | [10] | ||||
TF Protein Name |
Homeobox protein CDX-2 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Homeobox protein CDX-2 (CDX2), influenced by the faecalibacterium prausnitzii, has been reported to activate the transcription of SLC2A2 gene in health condition, which leads to an increased expression of the drug transporter Glucose transporter type 2. | |||||
DUX4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A2 gene | [9] | ||||
TF Protein Name |
Double homeobox protein 4 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Double homeobox protein 4 (DUX4) can directly bind to the SLC2A2 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 2. | |||||
HNF1A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A2 gene in type 2 diabetes condition | [11] | ||||
TF Protein Name |
Hepatocyte nuclear factor 1-alpha | Transcription Factor Info | ||||
Studied Phenotype |
Type 2 diabetes [ICD11: 5A11] | |||||
Tissue |
Embryo | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Mouse embryo fibroblast cells (NIH-3T3) | |||||
Detailed Description |
Hepatocyte nuclear factor 1-alpha (HNF1A) has been reported to activate the transcription of SLC2A2 gene in type 2 diabetes condition, which leads to an increased expression of the drug transporter Glucose transporter type 2. | |||||
HNF1B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A2 gene in renal cysts condition | [12] | ||||
TF Protein Name |
Hepatocyte nuclear factor 1-beta | Transcription Factor Info | ||||
Studied Phenotype |
Renal cysts [ICD11: GB80] | |||||
Tissue |
Kidney | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Zebrafish TgPT::EGFP) | |||||
Detailed Description |
Hepatocyte nuclear factor 1-beta (HNF1B) has been reported to activate the transcription of SLC2A2 gene in renal cysts condition, which leads to an increased expression of the drug transporter Glucose transporter type 2. | |||||
NKX6-1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A2 gene in diabetes mellitus condition | [13] | ||||
TF Protein Name |
Homeobox protein Nkx-6.1 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Glucose | |||||
Studied Phenotype |
Diabetes mellitus [ICD11: 5A10-5A14] | |||||
Tissue |
Pancreas | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
129Sv-C57BL6/J hybrid mice | |||||
Detailed Description |
Homeobox protein Nkx-6.1 (NKX6-1) has been reported to activate the transcription of SLC2A2 gene in diabetes mellitus condition, which leads to an increased expression of the drug transporter Glucose transporter type 2. | |||||
ONECUT1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A2 gene in hepatoblastoma condition | [14] | ||||
TF Protein Name |
Hepatocyte nuclear factor 6 | Transcription Factor Info | ||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Hepatocyte nuclear factor 6 (ONECUT1) has been reported to activate the transcription of SLC2A2 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Glucose transporter type 2. | |||||
PBX3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A2 gene | [2] | ||||
TF Protein Name |
Pre-B-cell leukemia transcription factor 3 | Transcription Factor Info | ||||
Tissue |
Blood; Brain | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Pre-B-cell leukemia transcription factor 3 (PBX3) can directly bind to the SLC2A2 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 2. | |||||
Class 3.2: Paired box factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
PAX6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of SLC2A2 gene in diabetes mellitus condition | [15] | ||||
TF Protein Name |
Paired box protein Pax-6 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Insulin | |||||
Studied Phenotype |
Diabetes mellitus [ICD11: 5A10-5A14] | |||||
Tissue |
Pancreas | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Pax6 KO mice | |||||
Detailed Description |
Paired box protein Pax-6 (PAX6) has been reported to repress the transcription of SLC2A2 gene in diabetes mellitus condition, which leads to a decreased expression of the drug transporter Glucose transporter type 2. | |||||
Class 3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
FOXA2 |
Click to Show/Hide to Show 3 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A2 gene in type 2 diabetes condition | [11] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Studied Phenotype |
Type 2 diabetes [ICD11: 5A11] | |||||
Tissue |
Embryo | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Mouse embryo fibroblast cells (NIH-3T3) | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to activate the transcription of SLC2A2 gene in type 2 diabetes condition, which leads to an increased expression of the drug transporter Glucose transporter type 2. | |||||
Transcriptional Phenomenon 2 |
Repression of SLC2A2 gene in insulinoma condition | [16] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Affected Drug/Substrate |
Glucose | |||||
Studied Phenotype |
Insulinoma [ICD11: 2C10.1] | |||||
Tissue |
Pancreas | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Rat insulinoma cells (INS-1) | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to repress the transcription of SLC2A2 gene in insulinoma condition, which leads to a decreased expression of the drug transporter Glucose transporter type 2. | |||||
Transcriptional Phenomenon 3 |
Repression of SLC2A2 gene in hepatoblastoma condition | [14] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to repress the transcription of SLC2A2 gene in hepatoblastoma condition, which leads to a decreased expression of the drug transporter Glucose transporter type 2. | |||||
FOXA3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A2 gene in effects of | [17] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-gamma | Transcription Factor Info | ||||
Affected Drug/Substrate |
Glucose | |||||
Studied Phenotype |
Effects of hunger [ICD11: NF07.0] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Hepatocyte nuclear factor 3-gamma (FOXA3) has been reported to activate the transcription of SLC2A2 gene in effects of hunger condition, which leads to an increased expression of the drug transporter Glucose transporter type 2. | |||||
Class 3.7: ARID domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
ARID3A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A2 gene | [8] | ||||
TF Protein Name |
AT-rich interactive domain-containing protein 3A | Transcription Factor Info | ||||
Tissue |
Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
AT-rich interactive domain-containing protein 3A (ARID3A) can directly bind to the SLC2A2 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 2. | |||||
Class 6.2: STAT domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
STAT3 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A2 gene in obesity condition | [18] | ||||
TF Protein Name |
Signal transducer and activator of transcription 3 | Transcription Factor Info | ||||
Affected Drug/Substrate |
2-deoxyglucose | |||||
Studied Phenotype |
Obesity [ICD11: 5B81] | |||||
Tissue |
Pancreas | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
RIP-Cre-STAT3/loxP hybrid mice | |||||
Detailed Description |
Signal transducer and activator of transcription 3 (STAT3) has been reported to activate the transcription of SLC2A2 gene in obesity condition, which leads to an increased expression of the drug transporter Glucose transporter type 2. | |||||
Transcriptional Phenomenon 2 |
Activation of SLC2A2 gene in health condition | [19] | ||||
TF Protein Name |
Signal transducer and activator of transcription 3 | Transcription Factor Info | ||||
Affected Drug/Substrate |
2-deoxyglucose | |||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
White Leghorn chicken hepatocyte isolates | |||||
Detailed Description |
Signal transducer and activator of transcription 3 (STAT3) has been reported to activate the transcription of SLC2A2 gene in health condition, which leads to an increased expression of the drug transporter Glucose transporter type 2. | |||||
Class 6.7: Grainyhead domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GRHL2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A2 gene | [3] | ||||
TF Protein Name |
Grainyhead-like protein 2 homolog | Transcription Factor Info | ||||
Tissue |
Breast; Bronchus; Ovary | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Grainyhead-like protein 2 homolog (GRHL2) can directly bind to the SLC2A2 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 2. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.